ASAM Weekly For December 13, 2022
December 13, 2022
December 13, 2022
CHEVY CHASE, Maryland, Dec. 13 (TNSjou) -- The American Society of Addiction Medicine issued the following news release:
It's been more than a decade since the MOTHER trial introduced many of us to the benefits of buprenorphine treatment in pregnancy. A larger, updated study has further supported its findings -- buprenorphine exposure in neonates results in more favorable outcomes than methadone (NEJM). The significance is underscored by another study making headlines -- drug o . . .
It's been more than a decade since the MOTHER trial introduced many of us to the benefits of buprenorphine treatment in pregnancy. A larger, updated study has further supported its findings -- buprenorphine exposure in neonates results in more favorable outcomes than methadone (NEJM). The significance is underscored by another study making headlines -- drug o . . .